consolidate shares on offer by a base of 10 to 20.
too much dilution, not based in oz
plus it is over valued in my opinion.
the pharma side with creams etc is a total flop atm, no imminent revenue even from oil that they will extract all of that is going into research somemight get sold to other reseaches but their is no retail stram atm.
its a bottom drawer for the next 4-5 years
consolidate shares on offer by a base of 10 to 20. too much...
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
